The Impact of Once-Nightly Versus Twice-Daily Dosing and Baseline Beliefs About HAART on Adherence to Efavirenz-Based HAART Over 48 Weeks: The NOCTE Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.